TARAProtara Therapeutics Inc
TARA
Protara Therapeutics Inc5,500
Mkt Cap
$277.45MVolume
405,484.0052W High
$7.8252W Low
$2.77PE Ratio
-3.84TARA Fundamentals
Price
$5.13Prev Close
$5.26Open
$5.2250D MA
$5.59Beta
1.22Avg. Volume
969,595.73EPS (Annual)
-$1.34P/B
1.40Rev/Employee
$0.00$76.12
Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, f...
MarketBeat·18h ago
Stock Traders Buy Large Volume of Protara Therapeutics Call Options (NASDAQ:TARA)
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock traders bought 2,120 call options on the stock. This represents an...
MarketBeat·18d ago
Jacqueline Zummo Sells 22,598 Shares of Protara Therapeutics (NASDAQ:TARA) Stock
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) insider Jacqueline Zummo sold 22,598 shares of Protara Therapeutics stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $5.26, for a total value of $118,865.48. Following the completion of the sale...
MarketBeat·24d ago
Insider Selling: Protara Therapeutics (NASDAQ:TARA) Insider Sells 22,598 Shares of Stock
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) insider Jacqueline Zummo sold 22,598 shares of the business's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $5.26, for a total transaction of $118,865.48. Following the transaction, the...
MarketBeat·24d ago
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat reports...
MarketBeat·26d ago
Protara Therapeutics, Inc. (NASDAQ:TARA) Sees Large Increase in Short Interest
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...
MarketBeat·29d ago
Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Up 48.0% in February
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) saw a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 4,895,488 shares, an...
MarketBeat·1mo ago
FY2030 Earnings Forecast for TARA Issued By HC Wainwright
Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) - Stock analysts at HC Wainwright issued their FY2030 earnings per share estimates for shares of Protara Therapeutics in a research note issued...
MarketBeat·2mo ago
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are currently covering the firm...
MarketBeat·2mo ago
Protara Therapeutics (NASDAQ:TARA) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on shares of Protara Therapeutics in a report on Wednesday. They issued an "overweight" rating and a $27.00 target price for the company...
MarketBeat·2mo ago
<
1
2
...
>